We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Immunologic Function in the Elderly After Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00447135
Recruitment Status : Completed
First Posted : March 14, 2007
Last Update Posted : January 30, 2008
Information provided by:

Study Description
Brief Summary:
The purpose of this research is to learn more about the function of the body's ability to fight infection when the immune response is activated when injury occurs, in the elderly population.

Condition or disease
Over the Age of 65 Admitted to the Trauma Service

  Show Detailed Description

Study Design

Study Type : Observational
Actual Enrollment : 55 participants
Time Perspective: Retrospective
Official Title: Immunologic Function in the Elderly After Injury: the Polymorphonuclear Leukocyte (PMN) and Innate Immunity
Study Start Date : March 2005
Primary Completion Date : December 2005
Study Completion Date : December 2005
Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   66 Years and older   (Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Elderly after injury

Inclusion Criteria:

  • Greater than 65
  • Admitted to the trauma service

Exclusion Criteria:

  • Inability to draw sufficient blood
  • Immunocompromised
  • Currently receiving systemic corticosteroids
  • Participation in other studies
  • In the opinion of the investigator will not be able to complete protocol
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00447135

United States, Ohio
Summa Health System
Akron, Ohio, United States, 44304
Sponsors and Collaborators
Summa Health System
Principal Investigator: William Fallon, MD Summa Health System
More Information

Responsible Party: Dr. William Fallon, Summa Health System
ClinicalTrials.gov Identifier: NCT00447135     History of Changes
Other Study ID Numbers: 04104
First Posted: March 14, 2007    Key Record Dates
Last Update Posted: January 30, 2008
Last Verified: January 2008

Keywords provided by Summa Health System:
Polymorphonuclear Leukocyte